| 2025-11-13 18:42 | CC:APLI | Appili Therapeutics Inc | 0.025 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-11-13 18:42 | CC:APLI | Appili Therapeutics Inc | 0.025 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-11-13 17:21 | CC:APLI | APPILI THERAPEUTICS INC. J | 0.025 | News Release200 | Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026 |
| 2025-11-05 15:11 | CC:APLI | Appili Therapeutics Inc | 0.025 | News Release200 | Appili Therapeutics arranges $750,000 private placement |
| 2025-10-22 07:20 | CC:APLI | APPILI THERAPEUTICS INC. J | 0.03 | News Release200 | Appili Therapeutics to Attend BARDA Innovation Symposium 2025 |
| 2025-10-01 17:08 | CC:APLI | Appili Therapeutics Inc | 0.04 | News Release200 | Appili, Vitalex win up to $40M (U.S.) VXV-01 contract |
| 2025-09-23 20:42 | CC:APLI | Appili Therapeutics Inc | 0.02 | News Release200 | Appili Therapeutics holders approve AGM resolutions |
| 2025-09-09 07:20 | CC:APLI | APPILI THERAPEUTICS INC. J | 0.015 | News Release200 | Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference |
| 2025-08-14 17:31 | CC:APLI | Appili Therapeutics Inc | 0.015 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-08-14 17:31 | CC:APLI | Appili Therapeutics Inc | 0.015 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-08-14 17:05 | CC:APLI | APPILI THERAPEUTICS INC. J | 0.015 | News Release200 | Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2026 |
| 2025-08-06 17:16 | CC:APLI | Appili Therapeutics Inc | 0.015 | News Release200 | Appili releases tularemia vaccine results |
| 2025-06-25 20:49 | CC:APLI | Appili Therapeutics Inc | 0.015 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
| 2025-06-25 20:39 | CC:APLI | Appili Therapeutics Inc | 0.015 | SEDAR MD & A815 | SEDAR MD & A |
| 2025-06-25 20:26 | CC:APLI | Appili Therapeutics Inc | 0.015 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2025-06-25 18:04 | CC:APLI | APPILI THERAPEUTICS INC. J | 0.015 | News Release200 | Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results |
| 2025-05-30 16:19 | CC:APLI | Appili Therapeutics Inc | 0.015 | News Release200 | Appili terminates arrangement with Aditxt |
| 2025-05-20 02:24 | CC:APLI | Appili Therapeutics Inc | 0.03 | News Release200 | Appili to receive termination fee from Aditxt |
| 2025-05-01 07:34 | CC:APLI | APPILI THERAPEUTICS INC. J | 0.03 | News Release200 | Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia |
| 2025-04-28 17:47 | CC:APLI | Appili Therapeutics Inc | 0.03 | News Release200 | Appili Therapeutics granted patents in U.S., Mexico |
| 2025-04-02 17:23 | CC:APLI | Appili Therapeutics Inc | 0.03 | News Release200 | Appili president to join Aditxt's April 4 update |
| 2025-03-18 17:35 | CC:APLI | Appili Therapeutics Inc | 0.035 | News Release200 | Appili Therapeutics submits U.S. funding applications |
| 2025-02-14 17:59 | CC:APLI | Appili Therapeutics Inc | 0.03 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2025-02-14 17:53 | CC:APLI | Appili Therapeutics Inc | 0.03 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2025-02-14 17:06 | CC:APLI | APPILI THERAPEUTICS INC. J | 0.03 | News Release200 | Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025 |